The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Biopharm GmbH
Heidelberg, Germany
A
11-50 Employees
1986
Key takeaway
BIOPHARM is a pioneer in the research and development of biologics, having successfully achieved Proof of Concept for its product pipeline, which is now being out-licensed for further clinical development. With over 30 years of expertise in biotechnology, BIOPHARM is dedicated to discovering innovative substances and technologies in regenerative medicine.
Reference
Core business
Biopharm - Innovators in regenerative medicine
Biopharm Services
Chesham, United Kingdom
A
11-50 Employees
1998
Key takeaway
The company, Biopharm Services Ltd, offers the BioSolve product range, which helps biopharmaceutical innovators reduce manufacturing costs and improve decision-making through standardized and impartial information. Their technology solutions and consultancy services are designed to enhance profitability and patient access within the biopharmaceutical manufacturing sector.
Reference
Core business
Homepage - Biopharm
ADVANCED MICRODEVICES PRIVATE LIMITED
Ambala, India
D
251-500 Employees
1997
Key takeaway
Advanced Microdevices (mdi) specializes in providing purification, separation, and fluid management solutions tailored for the healthcare sector, including critical applications in biopharmaceuticals. Their offerings include customization and rapid prototyping of essential consumables.
Reference
Product
Biopharmaceuticals
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Liofilchem
Roseto degli Abruzzi, Italy
B
51-100 Employees
1983
Key takeaway
Liofilchem has a strong focus on producing high-quality bacteriology products, including microbial identification and susceptibility testing systems that are relevant to the biopharmaceutical sector. With a commitment to research and development and compliance with international standards, Liofilchem ensures the reliability and effectiveness of its diagnostic solutions, which are essential for clinical and industrial microbiology.
Reference
Product
BioPharma
Biotech Pharma Services
Al Ain, United Arab Emirates
C
11-50 Employees
2007
Key takeaway
Biotech Pharma is a pharmaceutical company that focuses on acquiring and in-licensing products in areas like Hematology and Oncology, which aligns with the biopharmaceutical sector. With over a decade of experience, they emphasize quality and reliable delivery of medications, making them a key player in the pharmaceutical market.
Reference
Core business
Biotech - Pharma Services
Biotech Pharma Services is a pharmaceutical company focusing on growth through the acquisition and in-licensing of pharmaceutical products.
BioPro Biologics Pharmacy
Vancouver, Canada
A
11-50 Employees
2017
Key takeaway
BioPro emphasizes a collaborative healthcare approach, offering personalized treatment plans and in-depth consultations to optimize health and medication use. Their services include access to specialty products and clinical guidance, which may be relevant for those interested in biopharmaceuticals.
Reference
Service
Services - BioPro Biologics Pharmacy
Baxter Pharmaceutical Solutions LLC
Bloomington, United States
B
101-250 Employees
2002
Key takeaway
Simtra BioPharma Solutions specializes in partnering with pharmaceutical and biotechnology companies to enhance the commercialization of their biopharmaceutical products, particularly focusing on sterile injectables. They offer a comprehensive range of services, from clinical production to commercial launch, ensuring high product quality and compliance throughout the manufacturing process.
Reference
Core business
People of BioPharma Solutions
BioPharma Global
Vienna, United States
B
1-10 Employees
2017
Key takeaway
BioPharma Global is a regulatory affairs consulting firm that specializes in advancing the development and approvals of biopharmaceuticals, particularly for orphan diseases and conditions with high unmet medical needs. Their expertise includes orphan drug designations, expedited review programs, and comprehensive regulatory strategy support, which is crucial for product developers in the biopharmaceutical sector.
Reference
Core business
international-business1 - BioPharma Global
HELVETIC BIOPHARMA SA
Mezzovico-Vira, Switzerland
A
1-10 Employees
2011
Key takeaway
Helvetic BioPharma is an innovative biopharmaceutical company that specializes in manufacturing high-value biological products and active compounds, particularly in therapeutic areas such as Oncology and Hematology. The company employs advanced technologies, including the production of recombinant proteins and monoclonal antibodies, to enhance patient care.
Reference
Core business
Home - Helvetic Biopharma
Innovation.Quality. Performance. Helvetic BioPharma is committed to making a difference in the lives of patients. That’s why these three words represent our daily goal. scroll down Products Our products portfolio is mainly composed by recombinant proteins, hormones and peptides. PEGylation Long acting molecules through chemical modification of therapeutic proteins. CMO Our “mainstream” bioprocessing capacity can […]
BiosanaPharma
Leiden, Netherlands
A
1-10 Employees
2012
Key takeaway
BiosanaPharma is revolutionizing the production of monoclonal antibody (mAb) biologics through a highly scalable and flexible continuous process, significantly reducing manufacturing costs for biologics and biosimilars.
Reference
Core business
BiosanaPharma
Technologies which have been searched by others and may be interesting for you:
Biopharmaceuticals are medicinal products created using biotechnology. These products often consist of proteins, nucleic acids, or living cells that are engineered to treat diseases. They differ from traditional pharmaceuticals, which are typically small chemical compounds. The production process for biopharmaceuticals involves complex biological systems, such as microorganisms or cultured cells, to produce therapeutic agents. Common examples include monoclonal antibodies, vaccines, and gene therapies, which are designed to target specific diseases, providing innovative treatment options in modern medicine.
Biopharmaceuticals are primarily derived from biological sources, such as living cells or organisms, which distinguishes them from traditional pharmaceuticals that are typically synthesized chemically. The production process for biopharmaceuticals often involves complex biological processes, including recombinant DNA technology, which allows for the creation of proteins and antibodies that can target specific diseases. In contrast, traditional pharmaceuticals are usually small molecules that are manufactured through chemical reactions and are often easier to produce and replicate. This fundamental difference leads to variations in efficacy, safety profiles, and mechanisms of action between the two categories, with biopharmaceuticals often providing targeted therapies for complex conditions, such as cancer and autoimmune diseases.
1. Targeted Therapy
Biopharmaceutical products are designed to target specific biological pathways or proteins in the body, leading to more effective treatments with fewer side effects compared to traditional pharmaceuticals. This precision allows for tailored therapies that can improve patient outcomes significantly.
2. Innovation and Development
The biopharmaceutical industry is at the forefront of innovation, constantly developing new therapies to address unmet medical needs. These advancements often result in groundbreaking treatments for complex diseases, including various forms of cancer, autoimmune disorders, and genetic conditions, thus enhancing the overall standard of care.
Biopharmaceutical research involves several key phases to develop new drugs and therapies. Initially, researchers focus on identifying biological targets, such as proteins or genes associated with diseases. This is often followed by a discovery phase where potential drug candidates are screened for their efficacy and safety. After identifying promising candidates, extensive preclinical testing takes place, utilizing in vitro (test tube) and in vivo (animal) models to evaluate the drug's biological activity and potential side effects. Successful candidates then progress to clinical trials, where they undergo rigorous testing in human subjects across multiple phases. Throughout this process, regulatory compliance is critical, ensuring that all research adheres to established guidelines to protect participant safety and ensure data integrity.
The biopharmaceutical industry faces several significant challenges that impact its growth and innovation. One major issue is the high cost of research and development, which can exceed billions of dollars for new drug candidates. This financial burden often leads to longer timelines for product development and increases the risk of failure during clinical trials. Another challenge is regulatory compliance. Navigating the complex landscape of regulations set by authorities such as the FDA can be daunting. Companies must ensure that their products meet rigorous safety and efficacy standards, which can slow down the approval process. Additionally, competition is fierce, with many players vying for market share, necessitating continual innovation and investment in cutting-edge technologies to stay ahead.
Some interesting numbers and facts about your company results for Biopharmaceutical
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 8633 |
| Amount of suitable service providers | 6797 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1983 |
| Youngest suiting company | 2017 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for Biopharmaceutical
What are related technologies to Biopharmaceutical?
Based on our calculations related technologies to Biopharmaceutical are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Biopharmaceutical?
The most represented industries which are working in Biopharmaceutical are Pharmaceuticals, Biotechnology, Other, Healthcare, Medical
How does ensun find these Biopharmaceutical Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
